EMA’s templates for product information
A page that lists the templates for product information for use by applicants and marketing-authorisation holders. The European Medicines Agency’s Working Group on Quality Review of Documents (QRD) develops, reviews and updates these templates. VIEW THE SOURCE
Chinese medicines: MHRA warning about their potential dangers
The MHRA warned people not to buy or use potentially dangerous unlicensed Chinese medicines sold online after some products were found to contain excessive levels of mercury or lead. VIEW THE SOURCE
Important note on document formats for EMA documents
All Microsoft Office documents submitted to the European Medicines Agency must be in a format compatible with MS Office 2003. Office 2007 and Office 2010 formats cannot currently be accepted.VIEW THE SOURCE
Parallel drugs from EU can be marketed in the UK
The UK Parallel Import Licensing Scheme allows medicinal products authorised in other EU Member States to be marketed in the UK, provided the imported products have no therapeutic difference from the equivalent UK products.VIEW THE SOURCE
